サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：メタボロミクスの世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023年から2030年予測
市場調査レポート
商品コード
1306545

メタボロミクスの世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023年から2030年予測

Global Metabolomics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日: | 発行: Value Market Research | ページ情報: 英文 221 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
メタボロミクスの世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023年から2030年予測
出版日: 2023年06月01日
発行: Value Market Research
ページ情報: 英文 221 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

メタボロミクス市場の世界需要は、2022年の38億9,000万米ドルから2030年には118億2,000万米ドル近くの市場規模に達すると推定され、調査期間2023年～2030年のCAGRは14.9%です。

メタボロミクスは、生物システム内の代謝物として知られる低分子の包括的な分析と測定に焦点を当てた科学研究の分野です。血液、尿、組織、細胞などの生体試料中に存在する代謝物を同定・定量し、さまざまな生物学的プロセスにおける代謝物の役割を理解することを目的としています。代謝物の分析により、代謝状態、生化学的変化、生物の全体的な生理学的状態に関する貴重な洞察が得られます。

市場力学：

質量分析計や核磁気共鳴分光法などの分析技術の進歩により、メタボロミクス分析の能力と感度が向上し、研究および応用における需要が高まっています。個別化医療へのシフトは、患者のメタボロームの包括的なプロファイリングに対する需要を生み出しています。この研究は、疾患に関連する固有の代謝シグネチャを特定し、早期診断、患者の層別化、個別化治療アプローチを可能にする上で重要な役割を果たします。疾患検出、予後予測、治療モニタリングのための正確なバイオマーカーの必要性も、メタボロミクスの採用を後押ししています。メタボロミクスは、製薬業界やバイオテクノロジー業界における創薬や薬剤開発に利用されています。薬物代謝の理解、薬物標的の特定、薬物の安全性プロファイルの評価に役立ち、薬物開発プロセスの最適化と患者の転帰に貢献します。メタボロミクスは農業や食品科学にも応用され、作物の改良、食品の品質評価、植物や微生物の代謝の理解に貢献しています。政府のイニシアチブ、支援資金、科学コミュニティ内での協力が、この市場の成長と採用をさらに後押ししています。

調査は、ポーターのファイブフォースモデル、市場魅力度分析、バリューチェーン分析をカバーしています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールはメタボロミクスの世界市場における各セグメントを包括的に評価することもできます。メタボロミクス産業の成長と動向は、本調査に総合的なアプローチを提供します。

地域分析：

本セクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東アフリカにおけるメタボロミクス市場の現在と将来の需要を強調する地域展望をカバーします。さらに、すべての著名な地域における個々のアプリケーションセグメントの需要、推定・予測に焦点を当てています。

また、市場の主要企業の包括的なプロファイルと、世界の競合情勢の詳細な見解もカバーしています。メタボロミクス市場の主要企業には、Waters Corporation（米国）、Agilent Technologies（米国）、島津製作所（日本）、Thermo Fisher Scientific（米国）、Danaher Corporation（米国）、Bruker Corporation（米国）、PerkinElmer（米国）、Merck KGaA（ドイツ）、GE Healthcare（米国）、Hitachi High- Technologies Corporation（日本）、Human Metabolome Technologies, Inc.（日本）、LECO Corporation（米国）などがあります。このセクションは、主要なM&A、将来的な能力、パートナーシップ、財務概要、提携、新製品開発、新製品発売などの様々な戦略的発展を含む競合情勢の全体像で構成されています。

ご要望がございましたら、弊社までご連絡ください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたものを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 メタボロミクス-産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場魅力度分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 メタボロミクスの世界市場分析：製品・サービス別

  • 製品・サービス別概要
  • 実績データと予測データ
  • 製品・サービス別分析
  • メタボロミクス機器
  • 分離ツール（ガスクロマトグラフィー、高速液体クロマトグラフィー、超高速液体クロマトグラフィー、キャピラリー電気泳動）
  • 検出ツール（核磁気共鳴（NMR）分光法、質量分析（MS）、表面ベース質量分析）

第6章 メタボロミクスの世界市場分析：バイオインフォマティクスツールとサービス別

  • バイオインフォマティクスツールとサービス別の概要
  • 実績データと予測データ
  • バイオインフォマティクスツール・サービス別分析
  • バイオインフォマティクスサービス
  • バイオインフォマティクスツールとデータベース

第7章 メタボロミクスの世界市場分析：アプリケーション別

  • アプリケーション別概要
  • 実績データと予測データ
  • アプリケーション別分析
  • バイオマーカー探索
  • 創薬
  • 毒性試験
  • ニュートリゲノミクス
  • 機能ゲノミクス
  • 個別化医療
  • その他

第8章 メタボロミクスの世界市場分析：適応症別

  • 適応症別概要
  • 実績データと予測データ
  • 適応症別分析
  • がん
  • 心血管疾患
  • 神経疾患
  • 代謝疾患
  • 先天性代謝異常
  • その他

第9章 メタボロミクスの世界市場分析：エンドユーザー別

  • エンドユーザー別概要
  • 実績データと予測データ
  • エンドユーザー別分析
  • 学術・研究機関
  • 製薬・バイオテクノロジー企業
  • 受託研究機関
  • その他

第10章 メタボロミクスの世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米の売上分析
    • 概要、実績および予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州の売上分析
    • 概要、実績および予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋地域売上分析
    • 概要、実績および予測
    • アジア太平洋地域：セグメント別
    • アジア太平洋地域：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • その他アジア太平洋地域
  • ラテンアメリカ売上分析
    • 概要、実績および予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績および予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東とアフリカ

第11章 メタボロミクス企業の競合情勢

  • メタボロミクス市場競合
  • パートナーシップ/提携/合意
  • 合併・買収
  • 新製品の上市
  • その他の開発

第12章 企業プロファイル

  • 企業シェア分析
  • 市場集中度
  • Waters Corporation（US）
  • Agilent Technologies（US）
  • Shimadzu Corporation（Japan）
  • Thermo Fisher Scientific（US）
  • Danaher Corporation（US）
  • Bruker Corporation（US）
  • PerkinElmer（US）
  • Merck KGaA（Germany）
  • GE Healthcare（US）
  • Hitachi High-Technologies Corporation（Japan）
  • Human Metabolome Technologies Inc.（Japan）
  • LECO Corporation（US）
  • Metabolon Inc.（US）
  • Bio-Rad Laboratories（US）
  • Scion Instruments（US）
  • DANI Instruments S.p.A.（Italy）
  • GL Sciences（Japan）
  • SRI Instruments（US）
  • Kore Technology Ltd.（UK）
  • JASCO Inc.（US）

注-企業プロファイルにおいて、財務の詳細や最近の動向は、非公開会社の場合、入手可能であるか、またはカバーされていない可能性があります。

図表

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis by Product & Service (USD MN)
  • Metabolomics Instruments Market Sales by Geography (USD MN)
  • Separation Tools (Gas Chromatography, High-Performance Liquid Chromatography, Ultra-Performance Liquid Chromatography, Capillary Electrophoresis) Market Sales by Geography (USD MN)
  • Detection Tools (Nuclear Magnetic Resonance (NMR) Spectroscopy, Mass Spectrometry (MS), Surface-Based Mass Analysis) Market Sales by Geography (USD MN)
  • Analysis Market by Bioinformatics Tools And Services (USD MN)
  • Bioinformatics Services Market Sales by Geography (USD MN)
  • Bioinformatics Tools And Databases Market Sales by Geography (USD MN)
  • Analysis by Appication (USD MN)
  • Biomarker Discovery Market Sales by Geography (USD MN)
  • Drug Discovery Market Sales by Geography (USD MN)
  • Toxicology Testing Market Sales by Geography (USD MN)
  • Nutrigenomics Market Sales by Geography (USD MN)
  • Functional Genomics Market Sales by Geography (USD MN)
  • Personalized Medicine Market Sales by Geography (USD MN)
  • Other Market Sales by Geography (USD MN)
  • Analysis by Indication (USD MN)
  • Cancer Market Sales by Geography (USD MN)
  • Cardiovascular Disorders Market Sales by Geography (USD MN)
  • Neurological Disorders Market Sales by Geography (USD MN)
  • Metabolic Disorders Market Sales by Geography (USD MN)
  • Inborn Errors Of Metabolism Market Sales by Geography (USD MN)
  • Other Market Sales by Geography (USD MN)
  • Analysis by End User (USD MN)
  • Academic And Research Institutes Market Sales by Geography (USD MN)
  • Pharmaceutical & Biotechnology Companies Market Sales by Geography (USD MN)
  • Contract Research Organizations Market Sales by Geography (USD MN)
  • Other Market Sales by Geography (USD MN)
  • Global Metabolomics Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Metabolomics
  • Market Research Process
  • Market Research Methodology
  • Global Metabolomics Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product & Service
  • Market Attractiveness Analysis by Bioinformatics Tools And Services
  • Market Attractiveness Analysis by Appication
  • Market Attractiveness Analysis by Indication
  • Market Attractiveness Analysis by End User
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product & Service (USD MN)
  • Metabolomics Instruments Market Sales by Geography (USD MN)
  • Separation Tools (Gas Chromatography, High-Performance Liquid Chromatography, Ultra-Performance Liquid Chromatography, Capillary Electrophoresis) Market Sales by Geography (USD MN)
  • Detection Tools (Nuclear Magnetic Resonance (NMR) Spectroscopy, Mass Spectrometry (MS), Surface-Based Mass Analysis) Market Sales by Geography (USD MN)
  • Global Market Analysis by Bioinformatics Tools And Services (USD MN)
  • Bioinformatics Services Market Sales by Geography (USD MN)
  • Bioinformatics Tools And Databases Market Sales by Geography (USD MN)
  • Global Market Analysis by Appication (USD MN)
  • Biomarker Discovery Market Sales by Geography (USD MN)
  • Drug Discovery Market Sales by Geography (USD MN)
  • Toxicology Testing Market Sales by Geography (USD MN)
  • Nutrigenomics Market Sales by Geography (USD MN)
  • Functional Genomics Market Sales by Geography (USD MN)
  • Personalized Medicine Market Sales by Geography (USD MN)
  • Other Market Sales by Geography (USD MN)
  • Global Market Analysis by Indication (USD MN)
  • Cancer Market Sales by Geography (USD MN)
  • Cardiovascular Disorders Market Sales by Geography (USD MN)
  • Neurological Disorders Market Sales by Geography (USD MN)
  • Metabolic Disorders Market Sales by Geography (USD MN)
  • Inborn Errors Of Metabolism Market Sales by Geography (USD MN)
  • Other Market Sales by Geography (USD MN)
  • Global Market Analysis by End User (USD MN)
  • Academic And Research Institutes Market Sales by Geography (USD MN)
  • Pharmaceutical & Biotechnology Companies Market Sales by Geography (USD MN)
  • Contract Research Organizations Market Sales by Geography (USD MN)
  • Other Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the and are not limited to the TOC.

目次
Product Code: VMR112111504

The global demand for Metabolomics Market is presumed to reach the market size of nearly USD 11.82 BN by 2030 from USD 3.89 BN in 2022 with a CAGR of 14.9% under the study period 2023 - 2030.

Metabolomics is a field of scientific study that focuses on the comprehensive analysis and measurement of small molecules, known as metabolites, within a biological system. It aims to identify and quantify metabolites present in biological samples, such as blood, urine, tissues, or cells, and to understand their roles in different biological processes. The analysis of metabolites provides valuable insights into the metabolic state, biochemical changes, and overall physiological condition of an organism.

MARKET DYNAMICS:

The advancements in analytical techniques, such as mass spectrometry and nuclear magnetic resonance spectroscopy, have expanded the capabilities and sensitivity of metabolomics analysis, driving its demand in research and applications. The shift towards personalized medicine has created a demand for comprehensive profiling of patients' metabolomes. The study plays a crucial role in identifying unique metabolic signatures associated with diseases, enabling early diagnosis, stratification of patients, and personalized treatment approaches. The need for accurate biomarkers for disease detection, prognosis, and therapeutic monitoring also fuels the adoption of metabolomics. It is used for drug discovery and development in the pharmaceutical and biotechnology industries. It aids in understanding drug metabolism, identifying drug targets, and assessing drug safety profiles, contributing to optimized drug development processes and patient outcomes. Metabolomics finds applications in agriculture and food science, contributing to crop improvement, food quality assessment, and understanding plant and microbial metabolism. Government initiatives, supportive funding, and collaborations within the scientific community further drive the growth and adoption of this market.

The research covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of metabolomics. The growth and trends of metabolomics industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the metabolomics market provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product & Service

  • Metabolomics Instruments
  • Separation Tools (Gas Chromatography, High-Performance Liquid Chromatography, Ultra-Performance Liquid Chromatography, Capillary Electrophoresis)
  • Detection Tools (Nuclear Magnetic Resonance (NMR) Spectroscopy, Mass Spectrometry (MS), Surface-Based Mass Analysis)

By Bioinformatics Tools And Services

  • Bioinformatics Services
  • Bioinformatics Tools And Databases

By Appication

  • Biomarker Discovery
  • Drug Discovery
  • Toxicology Testing
  • Nutrigenomics
  • Functional Genomics
  • Personalized Medicine
  • Other

By Indication

  • Cancer
  • Cardiovascular Disorders
  • Neurological Disorders
  • Metabolic Disorders
  • Inborn Errors Of Metabolism
  • Other

By End User

  • Academic And Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations
  • Other

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Metabolomics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the metabolomics market include Waters Corporation (US), Agilent Technologies (US), Shimadzu Corporation (Japan), Thermo Fisher Scientific (US), Danaher Corporation (US), Bruker Corporation (US), PerkinElmer (US), Merck KGaA (Germany), GE Healthcare (US), Hitachi High- Technologies Corporation (Japan). Human Metabolome Technologies, Inc. (Japan), LECO Corporation (US). Metabolon, Inc. (US), Bio-Rad Laboratories (US), Scion Instruments (US), DANI Instruments S.p.A. (Italy), GL Sciences (Japan), SRI Instruments (US), Kore Technology Ltd. (UK), and JASCO, Inc. (US) (Total 20 companies). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . METABOLOMICS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product & Service
    • 3.7.2 Market Attractiveness Analysis By Bioinformatics Tools And Services
    • 3.7.3 Market Attractiveness Analysis By Appication
    • 3.7.4 Market Attractiveness Analysis By Indication
    • 3.7.5 Market Attractiveness Analysis By End User
    • 3.7.6 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL METABOLOMICS MARKET ANALYSIS BY PRODUCT & SERVICE

  • 5.1 Overview by Product & Service
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Product & Service
  • 5.4 Metabolomics Instruments Historic and Forecast Sales by Regions
  • 5.5 Separation Tools (Gas Chromatography, High-Performance Liquid Chromatography, Ultra-Performance Liquid Chromatography, Capillary Electrophoresis) Historic and Forecast Sales by Regions
  • 5.6 Detection Tools (Nuclear Magnetic Resonance (NMR) Spectroscopy, Mass Spectrometry (MS), Surface-Based Mass Analysis) Historic and Forecast Sales by Regions

6 . GLOBAL METABOLOMICS MARKET ANALYSIS BY BIOINFORMATICS TOOLS AND SERVICES

  • 6.1 Overview by Bioinformatics Tools And Services
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Bioinformatics Tools And Services
  • 6.4 Bioinformatics Services Historic and Forecast Sales by Regions
  • 6.5 Bioinformatics Tools And Databases Historic and Forecast Sales by Regions

7 . GLOBAL METABOLOMICS MARKET ANALYSIS BY APPICATION

  • 7.1 Overview by Appication
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Appication
  • 7.4 Biomarker Discovery Historic and Forecast Sales by Regions
  • 7.5 Drug Discovery Historic and Forecast Sales by Regions
  • 7.6 Toxicology Testing Historic and Forecast Sales by Regions
  • 7.7 Nutrigenomics Historic and Forecast Sales by Regions
  • 7.8 Functional Genomics Historic and Forecast Sales by Regions
  • 7.9 Personalized Medicine Historic and Forecast Sales by Regions
  • 7.10. Other Historic and Forecast Sales by Regions

8 . GLOBAL METABOLOMICS MARKET ANALYSIS BY INDICATION

  • 8.1 Overview by Indication
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Indication
  • 8.4 Cancer Historic and Forecast Sales by Regions
  • 8.5 Cardiovascular Disorders Historic and Forecast Sales by Regions
  • 8.6 Neurological Disorders Historic and Forecast Sales by Regions
  • 8.7 Metabolic Disorders Historic and Forecast Sales by Regions
  • 8.8 Inborn Errors Of Metabolism Historic and Forecast Sales by Regions
  • 8.9 Other Historic and Forecast Sales by Regions

9 . GLOBAL METABOLOMICS MARKET ANALYSIS BY END USER

  • 9.1 Overview by End User
  • 9.2 Historical and Forecast Data
  • 9.3 Analysis by End User
  • 9.4 Academic And Research Institutes Historic and Forecast Sales by Regions
  • 9.5 Pharmaceutical & Biotechnology Companies Historic and Forecast Sales by Regions
  • 9.6 Contract Research Organizations Historic and Forecast Sales by Regions
  • 9.7 Other Historic and Forecast Sales by Regions

10 . GLOBAL METABOLOMICS MARKET ANALYSIS BY GEOGRAPHY

  • 10.1. Regional Outlook
  • 10.2. Introduction
  • 10.3. North America Sales Analysis
    • 10.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.3.2. North America By Segment Sales Analysis
    • 10.3.3. North America By Country Sales Analysis
    • 10.3.4. United State Sales Analysis
    • 10.3.5. Canada Sales Analysis
    • 10.3.6. Mexico Sales Analysis
  • 10.4. Europe Sales Analysis
    • 10.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.4.2. Europe by Segment Sales Analysis
    • 10.4.3. Europe by Country Sales Analysis
    • 10.4.4. United Kingdom Sales Analysis
    • 10.4.5. France Sales Analysis
    • 10.4.6. Germany Sales Analysis
    • 10.4.7. Italy Sales Analysis
    • 10.4.8. Russia Sales Analysis
    • 10.4.9. Rest Of Europe Sales Analysis
  • 10.5. Asia Pacific Sales Analysis
    • 10.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.5.2. Asia Pacific by Segment Sales Analysis
    • 10.5.3. Asia Pacific by Country Sales Analysis
    • 10.5.4. China Sales Analysis
    • 10.5.5. India Sales Analysis
    • 10.5.6. Japan Sales Analysis
    • 10.5.7. South Korea Sales Analysis
    • 10.5.8. Australia Sales Analysis
    • 10.5.9. Rest Of Asia Pacific Sales Analysis
  • 10.6. Latin America Sales Analysis
    • 10.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.6.2. Latin America by Segment Sales Analysis
    • 10.6.3. Latin America by Country Sales Analysis
    • 10.6.4. Brazil Sales Analysis
    • 10.6.5. Argentina Sales Analysis
    • 10.6.6. Peru Sales Analysis
    • 10.6.7. Chile Sales Analysis
    • 10.6.8. Rest of Latin America Sales Analysis
  • 10.7. Middle East & Africa Sales Analysis
    • 10.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.7.2. Middle East & Africa by Segment Sales Analysis
    • 10.7.3. Middle East & Africa by Country Sales Analysis
    • 10.7.4. Saudi Arabia Sales Analysis
    • 10.7.5. UAE Sales Analysis
    • 10.7.6. Israel Sales Analysis
    • 10.7.7. South Africa Sales Analysis
    • 10.7.8. Rest Of Middle East And Africa Sales Analysis

11 . COMPETITIVE LANDSCAPE OF THE METABOLOMICS COMPANIES

  • 11.1. Metabolomics Market Competition
  • 11.2. Partnership/Collaboration/Agreement
  • 11.3. Merger And Acquisitions
  • 11.4. New Product Launch
  • 11.5. Other Developments

12 . COMPANY PROFILES OF METABOLOMICS INDUSTRY

  • 12.1. Company Share Analysis
  • 12.2. Market Concentration Rate
  • 12.3. Waters Corporation (US)
    • 12.3.1. Company Overview
    • 12.3.2. Company Revenue
    • 12.3.3. Products
    • 12.3.4. Recent Developments
  • 12.4. Agilent Technologies (US)
    • 12.4.1. Company Overview
    • 12.4.2. Company Revenue
    • 12.4.3. Products
    • 12.4.4. Recent Developments
  • 12.5. Shimadzu Corporation (Japan)
    • 12.5.1. Company Overview
    • 12.5.2. Company Revenue
    • 12.5.3. Products
    • 12.5.4. Recent Developments
  • 12.6. Thermo Fisher Scientific (US)
    • 12.6.1. Company Overview
    • 12.6.2. Company Revenue
    • 12.6.3. Products
    • 12.6.4. Recent Developments
  • 12.7. Danaher Corporation (US)
    • 12.7.1. Company Overview
    • 12.7.2. Company Revenue
    • 12.7.3. Products
    • 12.7.4. Recent Developments
  • 12.8. Bruker Corporation (US)
    • 12.8.1. Company Overview
    • 12.8.2. Company Revenue
    • 12.8.3. Products
    • 12.8.4. Recent Developments
  • 12.9. PerkinElmer (US)
    • 12.9.1. Company Overview
    • 12.9.2. Company Revenue
    • 12.9.3. Products
    • 12.9.4. Recent Developments
  • 12.10. Merck KGaA (Germany)
    • 12.10.1. Company Overview
    • 12.10.2. Company Revenue
    • 12.10.3. Products
    • 12.10.4. Recent Developments
  • 12.11. GE Healthcare (US)
    • 12.11.1. Company Overview
    • 12.11.2. Company Revenue
    • 12.11.3. Products
    • 12.11.4. Recent Developments
  • 12.12. Hitachi High- Technologies Corporation (Japan)
    • 12.12.1. Company Overview
    • 12.12.2. Company Revenue
    • 12.12.3. Products
    • 12.12.4. Recent Developments
  • 12.13. Human Metabolome Technologies Inc. (Japan)
    • 12.13.1. Company Overview
    • 12.13.2. Company Revenue
    • 12.13.3. Products
    • 12.13.4. Recent Developments
  • 12.14. LECO Corporation (US)
    • 12.14.1. Company Overview
    • 12.14.2. Company Revenue
    • 12.14.3. Products
    • 12.14.4. Recent Developments
  • 12.15. Metabolon Inc. (US)
    • 12.15.1. Company Overview
    • 12.15.2. Company Revenue
    • 12.15.3. Products
    • 12.15.4. Recent Developments
  • 12.16. Bio-Rad Laboratories (US)
    • 12.16.1. Company Overview
    • 12.16.2. Company Revenue
    • 12.16.3. Products
    • 12.16.4. Recent Developments
  • 12.17. Scion Instruments (US)
    • 12.17.1. Company Overview
    • 12.17.2. Company Revenue
    • 12.17.3. Products
    • 12.17.4. Recent Developments
  • 12.18. DANI Instruments S.p.A. (Italy)
    • 12.18.1. Company Overview
    • 12.18.2. Company Revenue
    • 12.18.3. Products
    • 12.18.4. Recent Developments
  • 12.19. GL Sciences (Japan)
    • 12.19.1. Company Overview
    • 12.19.2. Company Revenue
    • 12.19.3. Products
    • 12.19.4. Recent Developments
  • 12.20. SRI Instruments (US)
    • 12.20.1. Company Overview
    • 12.20.2. Company Revenue
    • 12.20.3. Products
    • 12.20.4. Recent Developments
  • 12.21. Kore Technology Ltd. (UK)
    • 12.21.1. Company Overview
    • 12.21.2. Company Revenue
    • 12.21.3. Products
    • 12.21.4. Recent Developments
  • 12.22. JASCO Inc. (US)
    • 12.22.1. Company Overview
    • 12.22.2. Company Revenue
    • 12.22.3. Products
    • 12.22.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies